We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.62%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
–
AUM
$29.5B
AUM Growth
+$4.81B
(+20%)
Cap. Flow
+$2.82B
Cap. Flow
% of AUM
9.58%
Top 10 Holdings %
Top 10 Hldgs %
32.79%
Holding
1,495
New
316
Increased
416
Reduced
406
Closed
318
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$596M |
| 2 |
Apple
AAPL
|
+$461M |
| 3 |
Meta Platforms (Facebook)
META
|
+$411M |
| 4 |
Micron Technology
MU
|
+$296M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$361M |
| 2 |
Netflix
NFLX
|
+$303M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$303M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$240M |
| 5 |
T-Mobile US
TMUS
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.78% |
| 2 | Consumer Discretionary | 14.1% |
| 3 | Communication Services | 12.23% |
| 4 | Healthcare | 10.23% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Pacira BioSciences
PCRX
$997M
| $4.17M | 0.01% |
68,766
| – | – |
|
527
Graco
GGG
$13.5B
| $4.13M | 0.01% |
54,486
-1,353,334
| -96% | -$102M |
|
|
CTLP
528
DELISTED
Cantaloupe
CTLP
| $4.11M | 0.01% |
+346,158
| New | +$4.06M |
|
|
HOME
529
DELISTED
At Home Group Inc.
HOME
| $4.08M | 0.01% |
110,822
+74,208
| +203% | +$2.53M |
|
530
Inspire Medical Systems
INSP
$1.74B
| $4.07M | 0.01% |
+21,038
| New | +$4.17M |
|
531
News Corp Class B
NWS
$17.5B
| $4.06M | 0.01% |
166,551
+165,110
| +11,458% | +$4.08M |
|
532
Simmons First National
SFNC
$3.39B
| $4.03M | 0.01% |
+137,316
| New | +$4.1M |
|
533
Commercial Vehicle Group
CVGI
$147M
| $4.01M | 0.01% |
377,168
-50,001
| -12% | -$553K |
|
534
HCA Healthcare
HCA
$89.5B
| $3.98M | 0.01% |
+19,253
| New | +$3.92M |
|
535
Principal Financial Group
PFG
$24.3B
| $3.97M | 0.01% |
62,815
-349,033
| -85% | -$22.3M |
|
536
Cytokinetics
CYTK
$10.4B
| $3.93M | 0.01% |
198,633
-32,399
| -14% | -$761K |
|
537
Outset Medical
OM
$90.8M
| $3.93M | 0.01% |
+5,244
| New | +$4.01M |
|
538
Cavco Industries
CVCO
$4.55B
| $3.86M | 0.01% |
17,354
-11,484
| -40% | -$2.5M |
|
539
Kinross Gold
KGC
$32.8B
| $3.84M | 0.01% |
+604,945
| New | +$4.49M |
|
540
Amphastar Pharmaceuticals
AMPH
$916M
| $3.83M | 0.01% |
190,017
+29,770
| +19% | +$561K |
|
541
MasterCraft Boat Holdings
MCFT
$590M
| $3.83M | 0.01% |
145,696
-50,347
| -26% | -$1.41M |
|
542
Associated Banc-Corp
ASB
$5.91B
| $3.82M | 0.01% |
186,482
+163,904
| +726% | +$3.62M |
|
543
NewMarket
NEU
$8.18B
| $3.81M | 0.01% |
11,823
+9,148
| +342% | +$3.2M |
|
544
Liquidity Services
LQDT
$1.32B
| $3.79M | 0.01% |
148,719
| – | – |
|
545
Manhattan Associates
MANH
$11.4B
| $3.77M | 0.01% |
25,995
-25,205
| -49% | -$3.36M |
|
546
Westlake Corp
WLK
$9.9B
| $3.75M | 0.01% |
41,592
-1,684,762
| -98% | -$164M |
|
|
COWN
547
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $3.73M | 0.01% |
+90,946
| New | +$3.57M |
|
548
A.O. Smith
AOS
$8.7B
| $3.7M | 0.01% |
51,304
-19,652
| -28% | -$1.36M |
|
|
AQUA
549
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $3.67M | 0.01% |
108,752
-395,069
| -78% | -$11.9M |
|
|
NXGN
550
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.66M | 0.01% |
220,681
+106,798
| +94% | +$1.91M |
|
Similar funds
Assenagon Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Assenagon Asset Management held 1,495 positions worth $29.5B, up 20% from $24.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Assenagon Asset Management deployed $2.82B of net new capital in Q2 2021, opening 316 new positions and adding to 416 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 1,426,193 shares worth $262M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Walt Disney, an estimated $361M trimmed.
- Assenagon Asset Management's largest Q2 2021 buy was Alexion Pharmaceuticals: 1,426,193 shares worth $262M.
- Assenagon Asset Management added most to Amazon in Q2 2021, an estimated $596M increase.
- Assenagon Asset Management's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $361M.
- Assenagon Asset Management fully exited INPHI CORPORATION in Q2 2021, selling an estimated $47.9M.
- Assenagon Asset Management's ten largest holdings make up 33% of its $29.5B portfolio in Q2 2021.
- Assenagon Asset Management opened 316 new positions and closed 318 in Q2 2021.
- Assenagon Asset Management's portfolio value rose 20% quarter-over-quarter to $29.5B.
Based on Assenagon Asset Management's 13F filing for Q2 2021, filed 15 Jul 2021.